Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19142 | 453 | 26.8 | 58% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OK 432 | Author keyword | 42 | 37% | 20% | 92 |
2 | OK432 | Author keyword | 7 | 42% | 3% | 13 |
3 | PROD LIFECYCLE MED INFORMAT | Address | 6 | 100% | 1% | 4 |
4 | PROD S | Address | 5 | 54% | 2% | 7 |
5 | OK 432 PICIBANIL | Author keyword | 4 | 67% | 1% | 4 |
6 | CYTOTOXIC CD4 T CELL | Author keyword | 2 | 67% | 0% | 2 |
7 | TH1 TYPE CYTOKINES | Author keyword | 2 | 40% | 1% | 4 |
8 | AUTOLOGOUS TUMOR KILLING | Author keyword | 1 | 50% | 0% | 2 |
9 | PICIBANIL | Author keyword | 1 | 20% | 1% | 5 |
10 | ADOPTIVE IMMUNOTHERAPY AIT | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OK 432 | 42 | 37% | 20% | 92 | Search OK+432 | Search OK+432 |
2 | OK432 | 7 | 42% | 3% | 13 | Search OK432 | Search OK432 |
3 | OK 432 PICIBANIL | 4 | 67% | 1% | 4 | Search OK+432+PICIBANIL | Search OK+432+PICIBANIL |
4 | CYTOTOXIC CD4 T CELL | 2 | 67% | 0% | 2 | Search CYTOTOXIC+CD4+T+CELL | Search CYTOTOXIC+CD4+T+CELL |
5 | TH1 TYPE CYTOKINES | 2 | 40% | 1% | 4 | Search TH1+TYPE+CYTOKINES | Search TH1+TYPE+CYTOKINES |
6 | AUTOLOGOUS TUMOR KILLING | 1 | 50% | 0% | 2 | Search AUTOLOGOUS+TUMOR+KILLING | Search AUTOLOGOUS+TUMOR+KILLING |
7 | PICIBANIL | 1 | 20% | 1% | 5 | Search PICIBANIL | Search PICIBANIL |
8 | ADOPTIVE IMMUNOTHERAPY AIT | 1 | 50% | 0% | 1 | Search ADOPTIVE+IMMUNOTHERAPY+AIT | Search ADOPTIVE+IMMUNOTHERAPY+AIT |
9 | CLONOTYPIC PCR | 1 | 50% | 0% | 1 | Search CLONOTYPIC+PCR | Search CLONOTYPIC+PCR |
10 | DEMETHYLPODOPHYLLOTOXIN | 1 | 50% | 0% | 1 | Search DEMETHYLPODOPHYLLOTOXIN | Search DEMETHYLPODOPHYLLOTOXIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STREPTOCOCCAL PREPARATION OK 432 | 35 | 54% | 10% | 45 |
2 | AGENT OK 432 | 24 | 91% | 2% | 10 |
3 | STREPTOCOCCAL PREPARATION | 14 | 31% | 8% | 38 |
4 | PREPARATION OK 432 | 9 | 67% | 2% | 8 |
5 | CANCER ASCITES | 6 | 71% | 1% | 5 |
6 | OK 432 | 6 | 17% | 7% | 31 |
7 | INHIBITORY FACTOR TGIF | 6 | 100% | 1% | 4 |
8 | SU STRAIN | 6 | 100% | 1% | 4 |
9 | CYTOKINE INDUCING ACTIVITY | 5 | 63% | 1% | 5 |
10 | ACIDIC GLYCOPROTEIN | 4 | 67% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
TREATMENT OF MALIGNANT-TUMORS WITH THE STREPTOCOCCAL PREPARATION OK-432 | 1992 | 0 | 42 | 88% |
Characterization of a Streptococcal antitumor glycoprotein (SAGP) | 1998 | 9 | 31 | 29% |
BIOLOGICAL SIGNIFICANCE OF AUTOLOGOUS TUMOR-KILLING ACTIVITY AND ITS INDUCTION THERAPY | 1993 | 6 | 48 | 29% |
THE CYTOLYTIC AND REGULATORY ROLE OF NATURAL-KILLER-CELLS IN HUMAN NEOPLASIA | 1986 | 17 | 74 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROD LIFECYCLE MED INFORMAT | 6 | 100% | 0.9% | 4 |
2 | PROD S | 5 | 54% | 1.5% | 7 |
3 | MED SCI RADIOL TECHNOL | 1 | 50% | 0.2% | 1 |
4 | PATERSON IMMUNOL | 1 | 50% | 0.2% | 1 |
5 | THER EUT PROD DEV | 1 | 50% | 0.2% | 1 |
6 | ORAL SURG HLTH BIOSCI | 0 | 33% | 0.2% | 1 |
7 | SUB MOL ORAL MED | 0 | 33% | 0.2% | 1 |
8 | UROONCOL DEF MED | 0 | 33% | 0.2% | 1 |
9 | DENT ORAL MAXILLO IAL SURG 2 | 0 | 20% | 0.2% | 1 |
10 | EXCELLENCE REPROD SCI | 0 | 20% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155008 | TOXICOL S 216 KASHIMA YODOGAWA KU//N CWS//ZAJDELA HEPATOMA |
2 | 0.0000130662 | TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY |
3 | 0.0000130167 | PSK//POLYSACCHAROPEPTIDE//POLYSACCHARIDE K |
4 | 0.0000099342 | Z 100//BCG VIABILITY//NATURAL IMMUNOMODULATOR |
5 | 0.0000096847 | MHC AF//IMMUNODIAG//CARBOHYDRATE COMPONENT |
6 | 0.0000090788 | ANTIGEN SHEDDING//ADOPTIVE CHEMOIMMUNOTHERAPY//DRUG RESISTANT TUMORS |
7 | 0.0000090575 | IP PA1//INTEGRATED HOLIST IMMUNOL//BIOTECHNOL MIYAMAE KU |
8 | 0.0000077689 | PIT CELLS//ACTIVATED NATURAL KILLER CELLS//A NK CELLS |
9 | 0.0000072698 | TOXOPLASMA LYSATE ANTIGEN//OBIOPEPTIDE//L5178Y R LYMPHOMA |
10 | 0.0000069801 | BOVINE BETALACTOGLOBULIN//MUCOSAL ANTIGENS//BR AMBEDKAR ROTARY CANC HOSP |